Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma.

× No keyword cloud information.

13 in total

1. Indium-111 octreotide scintigraphy for the detection of non-functioning metastases from differentiated thyroid cancer: diagnostic and prognostic value.

Authors: Marcel P M Stokkel; Robbert B Verkooijen; Jan W A Smit
Journal: Eur J Nucl Med Mol Imaging Date: 2004-02-26 Impact factor: 9.236

2. Post-surgical ablation of thyroid residues with radioiodine in Ukrainian children and adolescents affected by post-Chernobyl differentiated thyroid cancer.

Authors: V Oliynyk; O Epshtein; T Sovenko; M Tronko; R Elisei; F Pacini; A Pinchera
Journal: J Endocrinol Invest Date: 2001-06 Impact factor: 4.256

3. In vitro assays to test the interference of anti-thyroglobulin antibodies on thyroglobulin measurement.

Authors: Deolinda Madureira; Susana Prazeres; Márcia São Pedro; Teresa Pereira; Ana Paula Font; Maria João Bugalho
Journal: Endocrine Date: 2008-03-29 Impact factor: 3.633

4. I-131 therapy for thyroglobulin positive patients without anatomical evidence of persistent disease.

Authors: N Kamel; D Corapcioglu; M Sahin; A Gürsoy; O Küçük; G Aras
Journal: J Endocrinol Invest Date: 2004-11 Impact factor: 4.256

5. Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer.

Authors: S Lisi; F Menconi; M A Altea; L Agate; E Molinaro; M G Castagna; D Taddei; L Grasso; A Pinchera; R Elisei; M Marinò
Journal: J Endocrinol Invest Date: 2004 Jul-Aug Impact factor: 4.256

6. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.

Authors: N Lima; H Cavaliere; E Tomimori; M Knobel; G Medeiros-Neto
Journal: J Endocrinol Invest Date: 2002-02 Impact factor: 4.256

7. Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment.

Authors: Ji Min Han; Won Bae Kim; Ji Hye Yim; Won Gu Kim; Tae Yong Kim; Jin-Sook Ryu; Gyungyub Gong; Tae-Yon Sung; Jong Ho Yoon; Suck Joon Hong; Eui Young Kim; Young Kee Shong
Journal: Thyroid Date: 2012-07-10 Impact factor: 6.568

8. Low thyroglobulin concentrations after thyroidectomy increase the prognostic value of undetectable thyroglobulin levels on levo-thyroxine suppressive treatment in low-risk differentiated thyroid cancer.

Authors: A Piccardo; F Arecco; S Morbelli; P Bianchi; F Barbera; M Finessi; S Corvisieri; E Pestarino; L Foppiani; G Villavecchia; M Cabria; F Orlandi
Journal: J Endocrinol Invest Date: 2009-07-28 Impact factor: 4.256

9. Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases.

Authors: Levent Kabasakal; Nalan Alan Selçuk; Hojjet Shafipour; Ozlem Ozmen; Cetin Onsel; Ilhami Uslu
Journal: Eur J Nucl Med Mol Imaging Date: 2004-07-01 Impact factor: 9.236

10. Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.

Authors: Marcel P M Stokkel; Henna I E Reigman; Robbert B T Verkooijen; Jan W Smit
Journal: J Cancer Res Clin Oncol Date: 2003-05-15 Impact factor: 4.553